Cutler Group LP Biogen Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$256.56 - $292.34 $4 Million - $4.56 Million	-15,600 Reduced 87.15%	2,300 $0
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $4.9 Million - $5.95 Million	-19,400 Reduced 52.01%	17,900 $155,000
Q3 2022 Oct 25, 2022	BUY	$194.69 - $268.46 $38,938 - $53,691	200 Added 0.54%	37,300 $540,000
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $1.54 Million - $1.83 Million	-8,200 Reduced 18.1%	37,100 $61,000
Q1 2022 Apr 14, 2022	BUY	$193.77 - $244.14 $7.07 Million - $8.91 Million	36,500 Added 414.77%	45,300 $124,000
Q4 2021 Jan 18, 2022	BUY	$223.92 - $287.77 $1.9 Million - $2.45 Million	8,500 Added 2833.33%	8,800 $11,000
Q3 2021 Oct 26, 2021	SELL	$282.99 - $369.05 $1.33 Million - $1.73 Million	-4,700 Reduced 94.0%	300 $0
Q2 2021 Jul 19, 2021	SELL	$259.0 - $414.71 $1.53 Million - $2.45 Million	-5,900 Reduced 54.13%	5,000 $9,000
Q1 2021 Apr 26, 2021	BUY	$242.95 - $284.63 $1.53 Million - $1.79 Million	6,300 Added 136.96%	10,900 $121,000
Q4 2020 Jan 21, 2021	BUY	$236.26 - $355.63 $141,756 - $213,378	600 Added 15.0%	4,600 $27,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $2.69 Million - $3.41 Million	-10,000 Reduced 71.43%	4,000 $109,000
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $2.11 Million - $2.92 Million	9,600 Added 218.18%	14,000 $188,000
Q3 2019 Oct 28, 2019	SELL	$217.44 - $243.88 $891,504 - $999,908	-4,100 Reduced 48.24%	4,400 $37,000
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $3.99 Million - $4.4 Million	-18,200 Reduced 68.16%	8,500 $16,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $2.58 Million - $4.03 Million	11,900 Added 80.41%	26,700 $83,000
Q4 2018 Feb 05, 2019	BUY	$278.5 - $352.75 $445,600 - $564,400	1,600 Added 12.12%	14,800 $189,000
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $968,583 - $1.27 Million	-3,300 Reduced 20.0%	13,200 $520,000
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $103,008 - $122,764	-400 Reduced 2.37%	16,500 $586,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $5.7 Million - $8.06 Million	-21,900 Reduced 56.44%	16,900 $955,000
Q4 2017 Jan 17, 2018	SELL	$307.64 - $344.58 $6 Million - $6.72 Million	-19,500 Reduced 33.45%	38,800 $1.82 Million
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $16.4 Million - $19.2 Million	58,300	58,300 $2.09 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account